Doctor profile · Federal record

Dr. Natali Balog, MD

Rheumatology Physician (CMS: Rheumatology) · Granger, IN

  • NPI 1578552386
  • Accepts Medicare
  • 26 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
6901 N Main St Ste 102
Granger, IN 465308022
(574) 647-4500
fax (574) 647-6354
Additional location
3220 Beacon Pkwy
Granger, IN 465307196
(574) 999-8788
fax (574) 999-8781
Mailing address
3245 Health Dr Ste 100
Granger, IN 465301380

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
August 7, 2025
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Indiana #01060398A
Medicaid
IN #200528210

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1578552386. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
212,948
Distinct HCPCS
10
Medicare allowed
$2,991,916
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 117,422 37 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 39,405 48 $13
J3111 Injection, romosozumab-aqqg, 1 mg 15,810 13 $10
J0897 Injection, denosumab, 1 mg 14,940 157 $23
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 14,876 36 $42
J9312 Injection, rituximab, 10 mg 3,900 17 $78
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,015 20 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 1,276 638 $118
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 758 165 $58
96372 Injection of drug or substance under skin or into muscle 371 175 $13

In context: peer comparison

Among 2 peers in Granger Rheumatology Physician, average services per provider: 8,047. This provider delivers 26× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$732
Transactions
36
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 15 $201.85
Janssen Biotech, INC. 2 $124.19
Novartis Pharmaceuticals Corporation 5 $110.32
Ucb, INC. 3 $71.88
Amgen INC. 3 $59.29
Radius Health, INC. 2 $37.17
Genzyme Corporation 1 $29.98
Lilly USA, LLC 1 $26.08
Genentech USA, INC. 1 $21.68
AstraZeneca Pharmaceuticals Lp 1 $18.94
E.R. Squibb & Sons, L.L.C. 1 $16.70
GlaxoSmithKline, LLC. 1 $14.19

By nature of payment

Food and Beverage
$633
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
5,027
Patients
1,847
Total drug cost
$1,688,501
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 803 235 $30,375
Prednisone Generic 783 264 $8,418
Shingrix (Varicella-Zoster Ge/As01b/Pf) Brand 722 505 $154,725
Hydroxychloroquine Sulfate Generic 632 182 $50,223
Leflunomide Generic 452 139 $45,106
Duloxetine Hcl Generic 333 101 $12,143
Tramadol Hcl Generic 299 58 $2,291
Allopurinol Generic 212 67 $3,883
Sulfasalazine Generic 173 47 $4,879
Folic Acid Generic 157 55 $857

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Natali Balog's medical specialty?
Dr. Natali Balog practices Rheumatology Physician in Granger, IN.
Where does Dr. Natali Balog practice?
Dr. Natali Balog practices at 6901 N Main St Ste 102, Granger, IN 465308022. Office phone: 5746474500.
What is Dr. Natali Balog's NPI?
Dr. Natali Balog's National Provider Identifier (NPI) is 1578552386, issued by NPPES.
Does Dr. Natali Balog accept Medicare assignment?
Yes. Dr. Natali Balog accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Natali Balog commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.